Carbamic acid,1H-benzimidazol-2-yl-,methyl ester,mixt. with (âE)-â-[(2,4-dichlorophenyl)- methylene]-R-(1,1-dimethylethyl)-1H-1,2,4- triazole-1-ethanol and 3-(3,5-dichlorophenyl)-N-(1-methylethyl)-2,- 4-dioxo-1-imidazolidinecarboxamide (125753-36-8)
Identification |
Properties |
Safety Data |
|
|
Other Product
- Carbamic acid,1H-benzimidazol-2-yl-,methyl ester,mixt. with R-butyl-R-(2,4-dichlorophenyl)- 1H-1,2,4-triazole-1-ethanol
- Copper,[2-(hydroxy-kO)benzoato-kO](8- quinolinolato-kN1,kO8)-,mixt. with â-(4-chlorophenoxy)-R-(1,1-dimethylethyl)- 1H-1,2,4-triazole-1-ethanol and methyl 1H-benzimidazol-2-ylcarbamate
- Carbamic acid, 1H-benzimidazol-2-yl-, methyl ester, mixt. with 1-((2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl)methyl)-1H-1,2,4-triazole
- 1-Imidazolidinecarboxamide,N-(2-chloro-1-methylethyl)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-
- 1H-1,2,4-Triazole-1-ethanol,â-[(4-chlorophenyl) methylene]-R-(1,1-dimethylethyl)-
- 1H-1,2,4-Triazole-1-ethanol,R-(1,1-dimethylethyl)- R-[(4-fluorophenoxy)methyl]-â-methyl-
- 1H-1,2,4-Triazole-1-propanenitrile,R-[2-(4- chlorophenyl)ethyl]-R-phenyl-,mixt. with 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl]-1H-1,2,4-triazole
- Carbamic acid, 1H-benzimidazol-2-yl-, methyl ester, mixt. with 1-((bis(4-fluorophenyl)methylsilyl)methyl)-1H-1,2,4-triazole
- 1H-1,2,4-Triazole-1-ethanol,R-(2,4-dichlorophenyl)- â-methoxy-R-methyl-
- Gibb-3-ene-1,10-dicarboxylic acid,2,4a,7-trihydroxy-1-methyl-8-methylene-,1,4a-lactone,(1R,2â,4aR,4bâ,10â)-,mixt. with N-(1-ethyl-1H-pyrazol-5-yl)-N'- phenylurea
- Spirostan-1,2,3,4,5-pentol,(1â,2â,3â,4â,5â)-
- 1H-Indole-3-butanoic acid,1-[(4-bromophenyl)methyl]-5-methoxy- â,2-dimethyl-,(âS)-
- 1-Imidazolidinecarboxamide,N-(2-chloroethyl)-3-(3,5-dichlorophenyl)-2,4-dioxo-
- 1-Imidazolidinecarboxamide,N-(2-chloropropyl)-3-(3,5-dichlorophenyl)-2,4-dioxo-
- 1H-1,2,4-Triazole,1-[[2-(2,4-dichlorophenyl)- 4-propyl-1,3-dioxolan-2-yl]methyl]-,mixt. with tridemorph
- â-D-Glucopyranoside,(3â,15â)-20-(hexahydro- 1-methyl-1H-azepin-2-yl)-15-hydroxypregn- 5-en-3-yl 4-O-â-D-glucopyranosyl-
- 2-{5-[(3,5-dichlorophenyl)sulfanyl]-4-(1-methylethyl)-1-(3-nitrobenzyl)-1H-imidazol-2-yl}ethanol
- 3H-1,2,4-Triazole-3-thione,4-(3,4-dichlorophenyl)-2,4-dihydro-5-[[2-(4-pyridinyl)-1H-benzimidazol-1-yl]methyl]-
- Aspidospermidine-15-acetic acid,4-(acetyloxy)-6,7-didehydro-R-[(RS)- [(3R,5S)-5-ethyl-5-hydroxy-1-methyl-3- piperidinyl]methyl]-3-hydroxy-16-methoxy-3- (methoxycarbonyl)-1-methyl-R-(3-methyl- 1H-indol-2-yl)-,methyl ester,(2â,3â,4â,5R,12â,19R)-
- Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with rel-3-(aminosulfonyl)-4-chloro-N-[(2R,6S)- 2,6-dimethyl-1-piperidinyl]benzamide and (5'R)-12'-hydroxy-2'-(1-methylethyl)-5'- (phenylmethyl)ergotaman-3',6',18-trione monomethanesulfonate (salt)